PLGA Nanoparticles: A Next-Generation Approach for Dual-Drug Delivery Systems | ||||
Octahedron Drug Research | ||||
Articles in Press, Accepted Manuscript, Available Online from 18 June 2025 | ||||
Document Type: Review Articles | ||||
DOI: 10.21608/odr.2025.390611.1055 | ||||
![]() | ||||
Authors | ||||
Hend Diaa Abdullah ![]() ![]() | ||||
23 December street | ||||
Abstract | ||||
Poly (lactic-co-glycolic acid) (PLGA) is a potential polymer for nanoparticle-mediated medication delivery and is an FDA-approved polymer used in several applications. It is distinguished by its biodegradability and biocompatibility, as well as its capacity to distribute drugs to target organs, hence reducing side effects. This review looks at how lactic acid and glycolic acid, the two building blocks of this polymer, can be changed to create different structures and properties, including how quickly they break down. Various preparation techniques are examined, including salting-out, emulsion evaporation, and nanoprecipitation. PLGA is a special type of polymer that is commonly used to deliver two different anticancer or antibacterial drugs at the same time (dual drug delivery system), which will have a synergistic effect and avoid the problem of multidrug resistance (MDR). In addition, they can deliver vaccines and gene therapies and manage respiratory tract conditions, such as asthma and chronic obstructive pulmonary disease (COPD). Drugs can reach their target cells through passive diffusion, active transport, or receptor-mediated endocytosis. However, some harmful effects may limit how well medicine can spread; therefore, more research and careful changes to factors like size and surface charge are important to improve delivery and reduce adverse effects. | ||||
Keywords | ||||
Dual drug delivery systems; Poly-lactic-co-glycolic acid (PLGA) Nanoparticles; Biodegradable polymers; Cancer treatment; and Vaccine delivery | ||||
Statistics Article View: 97 |
||||